Arena Pharmaceuticals Stock News

Upgrades For Ultrapar Participacoes SA (NYSE: UGP), B of A Securities upgraded the stock from Neutral to Buy. For the fourth quarter, Ultrapar Participacoes had an EPS...

Tuesday's top analyst upgrades and downgrades included Apache, Broadcom, Caterpillar, Dollar General, Microsoft, NXP Semiconductors, Salesforce.com, Sirius XM, Slack and Yelp.

Apellis Pharmaceuticals (NASDAQ:APLS) initiated with an Outperform rating and a $54 (88% upside) price target at BMO.Arena Pharmaceuticals (NASDAQ:ARNA) initiated with a Buy rating and a $95 (126% ups

Arena Pharmaceuticals initiated with a Buy at Guggenheim Guggenheim ARNA

Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) traded down 5.4% on Monday . The company traded as low as $41.32 and last traded at $42.12, 527,329 shares were traded during trading. A decline of

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that James C. Mullen has agreed to serve as an independent senior advisor to the Company.

Bank of America upgraded shares of Arena Pharmaceuticals (NASDAQ:ARNA) from a neutral rating to a buy rating in a report published on Thursday, Briefing.com Automated Import reports. The firm currentl

Alliancebernstein L.P. increased its holdings in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 4.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Ex

Great West Life Assurance Co. Can acquired a new position in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commis

Axa boosted its stake in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 2.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). Th

Amalgamated Bank lifted its position in shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 6.3% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 9,058 s

Gainers Aurora Cannabis (NYSE: ACB) shares closed up 15.44% at $1.04 Tilray (NASDAQ: TLRY) shares closed up 15.19% at $9.10 Curaleaf Holdings (OTC: CURLF) shares...